From the Department of Psychiatry and Biobehavioral Sciences, David Geffen School of Medicine at University of California Los Angeles (Dr. IsHak); Department of Psychiatry and Behavioral Neurosciences, Cedars-Sinai Medical Center, Los Angeles, CA (Drs. IsHak, Ismail, Delaloye, Ha, and Bolotaulo); Max Planck Institute of Psychiatry, Munich, Germany (Dr. Elbau); Department of Psychiatry at Dartmouth-Hitchcock Medical Center, Lebanon, NH (Dr. Delaloye); Department of Psychiatry and Behavioral Sciences, Emory University School of Medicine (Dr. Ha); University of Southern California Institute for Global Health, Los Angeles, CA (Ms. Nashawati); Department of Psychiatry, Yale School of Medicine (Dr. Cassmassi); City of Hope, Duarte, CA (Dr. Wang).
Original manuscript received 6 January 2012; revised manuscript received 15 June 2012, accepted for publication subject to revision 5 August 2012; revised manuscript received 21 August 2012.
Correspondence: Waguih William IsHak, MD, FAPA, Department of Psychiatry and Behavioral Neurosciences, Cedars-Sinai Medical Center, 8730 Alden Dr., Thalians Building, W-157, Los Angeles, CA 90048. Email: [email protected]
